We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CoVLP

News List

Health Canada to review rolling submission for Medicago’s Covid-19 vaccine pharmaceutical-technology
April 27, 2021
Health Canada has accepted for review the first portion of the rolling submission by Medicago for its plant-derived adjuvanted Covid-19 vaccine candidate.
GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine pharmatimes
March 18, 2021
GlaxoSmithKline (GSK) and Canadian biopharma company Medicago have launched a Phase III trial of their adjuvanted plant-derived COVID-19 vaccine candidate.
Plant-based COVID-19 vaccine enters Phase I trials europeanpharmaceuticalreview
July 23, 2020
The vaccine containing a recombinant coronavirus virus-like particles (CoVLP) will be tested in three different doses and with two different adjuvants.